Jennifer Bares, MD
Dermatology · Homewood, ALNPI 1255862454
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Boehringer Ingelheim at 53.0% of the total. Reporting peaked in 2022 at $6,249 and has fallen 68.2% since, to $1,984 in 2025.
Across 265 payments — averaging $44.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$6K
- Incyte Corporation$804
- AbbVie$796
- Novartis$756
- Arcutis Biotherapeutics, Inc.$379
- UCB, Inc.$297
- plus $2K from 20 others
What the payments were for
- Consulting fees$5,10043%
- Travel & lodging$9258%
- Food & beverage$5,63348%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 9 | $6,228 |
| Incyte Corporation | 47 | $804 |
| AbbVie | 52 | $796 |
| Novartis | 28 | $756 |
| Arcutis Biotherapeutics, Inc. | 12 | $379 |
| UCB, Inc. | 12 | $297 |
| Sun Pharmaceutical Industries Inc. | 13 | $286 |
| Mayne Pharma Commercial LLC | 12 | $248 |
| Pfizer | 4 | $248 |
| Organon | 10 | $227 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $222 |
| E.r. Squibb & Sons, L.L.C. | 14 | $219 |
| Dermavant Sciences, Inc. | 6 | $203 |
| LEO Pharma Inc. | 6 | $135 |
| Galderma Laboratories, L.p. | 5 | $96 |
| Johnson & Johnson | 5 | $87 |
| Revance Therapeutics, Inc. | 1 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Amgen | 3 | $66 |
| Journey Medical Corporation | 3 | $64 |
| Botanix SB Inc | 3 | $59 |
| Kyowa Kirin, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $46 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $40 |
| Biofrontera Inc. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,758 in reported general payments places this provider in the 75th percentile of 168 dermatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $155,196 |
| Cosentyx Unoready PenSecukinumab | 13 | $119,284 |
| Dupixent PenDupilumab | 11 | $39,084 |
| Clobetasol Propionate | 54 | $2,193 |
| Fluorouracil | 19 | $1,830 |
| Ketoconazole | 48 | $1,136 |
| Clindamycin Phosphate | 21 | $914 |
| Triamcinolone Acetonide | 45 | $527 |
| Mupirocin | 48 | $440 |
| Hydrocortisone | 23 | $379 |
| Spironolactone | 11 | $133 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Homewood
- Rayna DyckHomewood$71K
- John VanloockMobile$1.4M
- James KrellBirmingham$944K
- Julie HarperBirmingham$920K
- Eric BaumGadsden$896K
- Corey HartmanBirmingham$573K
- Kevin NashAuburn$341K
- Boni ElewskiBirmingham$271K
- Tiffany MayoBirmingham$256K
- Porcia LoveMontgomery$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.